Literature DB >> 31099736

Faecalibacillus intestinalis gen. nov., sp. nov. and Faecalibacillus faecis sp. nov., isolated from human faeces.

Boram Seo1,2, Kyungchan Jeon1, Inwoo Baek2, Yung Mi Lee3, Kiwoon Baek4, GwangPyo Ko5,6,1,7.   

Abstract

Two long-rod-shaped, Gram-stain-positive, obligately anaerobic and non-spore-forming strains, SNUG30099T and SNUG30370T, were isolated from faecal samples of healthy Korean subjects. The strains formed circular ivory-coloured colonies on Brain-heart infusion medium supplemented with 0.5% Difco yeast extract (YBHI) agar and cells were approximately 3.5-4.5×0.3-0.4 µm in size. Taxonomic analyses based on 16S rRNA gene sequences distinguished the strains from other species within the family Erysipelotrichaceae. The closest relative of strains SNUG30099T and SNUG30370T was Longibaculum muris (92.9 % and 93.6 % similarity, respectively), followed by Clostridium saccharogumia (92.3 % and 92.2 %). Phylogenetic inference also divided the strains into a unique branch that differed from other related strains that belong to the family Erysipelotrichaceae. DNA G+C contents based on the whole genome sequences of strains SNUG30099T and SNUG30370T were 29.2 and 30.2 mol%, respectively. Both novel strains possessed meso-diaminopimelic acid as the peptidoglycan, and phosphatidylethanolamine was observed as one of the major polar lipids. The major cellular fatty acid composition was different from those of other related taxa. In addition, the profile of biochemical activities advocated that the strains have distinct characteristics in comparison to other strains. Taken together, a novel genus, named Faecalibacillus gen. nov., is proposed, which includes the type species Faecalibacillus intestinalis sp. nov. for strain SNUG30099T and Faecalibacillus faecis sp. nov. for strain SNUG30370T. The type strains of these novel species are SNUG30099T (=KCTC 15631T=JCM 32256T) and SNUG30370T (=KCTC 15632T=JCM 32257T).

Entities:  

Keywords:  Erysipelotrichaceae; human gut microbiota; new taxa

Mesh:

Substances:

Year:  2019        PMID: 31099736     DOI: 10.1099/ijsem.0.003443

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  4 in total

Review 1.  Summary of Novel Bacterial Isolates Derived from Human Clinical Specimens and Nomenclature Revisions Published in 2018 and 2019.

Authors:  Erik Munson; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

2.  Gut Microbiome in Progressive Multiple Sclerosis.

Authors:  Laura M Cox; Amir Hadi Maghzi; Shirong Liu; Stephanie K Tankou; Fyonn H Dhang; Valerie Willocq; Anya Song; Caroline Wasén; Shahamat Tauhid; Renxin Chu; Mark C Anderson; Philip L De Jager; Mariann Polgar-Turcsanyi; Brian C Healy; Bonnie I Glanz; Rohit Bakshi; Tanuja Chitnis; Howard L Weiner
Journal:  Ann Neurol       Date:  2021-04-30       Impact factor: 11.274

3.  Gut microbiome diversity and composition is associated with hypertension in women.

Authors:  Panayiotis Louca; Ana Nogal; Philippa M Wells; Francesco Asnicar; Jonathan Wolf; Claire J Steves; Tim D Spector; Nicola Segata; Sarah E Berry; Ana M Valdes; Cristina Menni
Journal:  J Hypertens       Date:  2021-09-01       Impact factor: 4.776

4.  Complete Genome Sequence of Faecalibacillus intestinalis JCM 34082, Isolated from Feces from a Healthy Japanese Female.

Authors:  Mitsuo Sakamoto; Nao Ikeyama; Atsushi Toyoda; Takumi Murakami; Hiroshi Mori; Moriya Ohkuma
Journal:  Microbiol Resour Announc       Date:  2020-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.